If you or a family member was seriously hurt during or after a Watchman heart implant, a Watchman device lawsuit is a realistic option worth evaluating. Cases filed so far have alleged manufacturing defects, failure to warn about procedural risks, and wrongful death against Boston Scientific, the device’s maker. A July 2025 FDA Class I recall tied to 17 deaths and 120 serious injuries during implantation has given new weight to failure-to-warn claims.
The Watchman is a small implant that seals off the left atrial appendage to lower stroke risk in people with atrial fibrillation. It is approved as a Class III medical device, the FDA’s most tightly regulated category, which shapes both the complications patients report and the legal arguments the manufacturer uses to defend itself.
What Watchman Lawsuits Allege
Claims against Boston Scientific generally fall into three categories.1Panter Law. Watchman Device Lawsuits: Legal Issues
Product liability claims allege the device was defectively designed or manufactured, or sold without adequate warnings. A manufacturing defect theory focuses on a specific unit deviating from the FDA-approved design, for example a device that broke free from its delivery wire during the implantation procedure.
Medical malpractice claims target the implanting physician rather than the manufacturer, arguing the doctor fell below the standard of care during the procedure or follow-up. These are state-law claims against the hospital or cardiologist.
Wrongful death claims are brought by the estate when complications proved fatal. The Watchman is implanted in older, higher-risk patients, and fatal outcomes have been reported from air embolism, cardiac perforation, stroke, and device migration.
There is no multidistrict litigation consolidating Watchman cases as of early 2026. A review of the Judicial Panel on Multidistrict Litigation’s 2025 docket does not show a Watchman petition among the product liability cases heard that year.2Dechert LLP. Product Liability Litigation and the 2025 Judicial Panel on Multidistrict Litigation Cases are filed individually in federal and state court.
The 2025 Recall and Why It Matters for Claims
On July 29, 2025, Boston Scientific sent clinicians an advisory warning of a significantly higher risk of air embolism when Watchman implantation is performed without positive pressure-controlled ventilation. The company’s own data showed that patients sedated but not mechanically ventilated were roughly three times more likely to develop negative pressure in the left atrium, letting air enter the bloodstream and cause stroke, organ failure, abnormal heart rhythm, or hemodynamic collapse.
As of July 30, 2025, Boston Scientific had reported 120 serious injuries and 17 deaths connected to the issue.3FDA. Vascular Access Systems Correction: Boston Scientific Updates Use Instructions for Watchman Access The FDA issued an early alert on August 11, 2025, and classified the correction as a Class I recall, its most serious category.4Cardiac Interventions Today. FDA Issues Early Alert on Boston Scientific’s Watchman Access System The recall covered the Watchman TruSeal, FXD Curve, and Trusteer access systems, with 340,185 units distributed worldwide.5FDA. Recall Detail: Z-2432-2025
Boston Scientific did not pull devices from the market. The company updated instructions for use and physician training, telling clinicians to confirm patients are not volume-depleted, to keep the access sheath valve below heart level or under fluid during device insertion and exchange, and to use the most appropriate anesthesia method.6MD+DI Online. FDA Updates Watchman Instruction Following 17 Deaths, 120 Injuries
One boundary to be clear about: the recall applies only to the implantation procedure. Patients who already have a Watchman device sitting in place do not need additional treatment because of this recall. The legal significance is on the front end. The recall centers on allegedly inadequate procedural instructions, which gives new factual support to failure-to-warn claims brought by patients injured during implantation.
Injuries That May Support a Claim
Legal teams reviewing Watchman cases are looking at a defined set of complications: device embolization (the implant migrating from its intended position), cardiac perforation, pericardial effusion or tamponade (fluid building up around the heart), stroke, device-related blood clots, and incomplete closure of the left atrial appendage.7Lawfold. Watchman Device Lawsuit
The FDA’s MAUDE adverse-event database held 10,998 reports linked to Watchman device components between 2019 and mid-2026, including 1,210 coded as deaths and 8,890 coded as injuries.8Claripulse. 10,998 Watchman Device Reports to FDA: What the MAUDE Data Reveals The most frequent patient-side complications in those reports were pericardial effusion (2,255), thrombosis or blood clots on the device (2,094), and stroke (1,168). The leading product-side problems were device migration (676) and dislodgement (609). MAUDE is a passive reporting system without a denominator of total implants, so the counts show what has been reported, not an incidence rate.
A known complication is not automatically a claim. But a complication the patient was never adequately warned about, or one made more likely by poor procedural instructions, inadequate monitoring, or a manufacturing defect in a specific unit, can be.1Panter Law. Watchman Device Lawsuits: Legal Issues
The Federal Preemption Hurdle
The single biggest legal obstacle in a Watchman case is federal preemption. Because the FDA approved the Watchman through premarket approval as a Class III device, Boston Scientific has argued that state-law product liability claims are blocked under the Supreme Court’s 2008 decision in Riegel v. Medtronic. That defense holds when the plaintiff’s theory would effectively require the manufacturer to do something different from, or in addition to, what the FDA approved.
The defense tends to break down where the plaintiff alleges the device violated the FDA’s own requirements, such as a manufacturing defect that caused a specific unit to deviate from the approved design. That is the theory that let the most prominent reported Watchman case survive dismissal.
How Earlier Cases Have Gone
The most publicly documented Watchman lawsuit was brought by the estate of Jean Penland, who died in 2018. The estate’s executor, Donna Shook, alleged the Watchman broke free from its core wire during implantation, lodged in Penland’s mitral valve, and required 77 minutes of bypass surgery to retrieve. The complaint alleged a “clear and specific manufacturing and assembly defect.”9MassDevice. Federal Judge Won’t Let Boston Sci Avoid Watchman Lawsuit
Boston Scientific moved to dismiss on preemption grounds. In March 2021, Judge Max O. Cogburn Jr. of the Western District of North Carolina denied the motion, finding the estate had pleaded enough facts to proceed. The parties settled before trial, and a stipulation of dismissal was filed on August 5, 2022. The financial terms were not publicly disclosed.10HarrisMartin. Settlement Reached in Action Targeting Boston Scientific’s Stroke Prevention Device
An earlier case, Dahl v. Atritech, involved a clinical trial participant whose 2004 implantation went wrong when the device failed to detach from the delivery wire and the wire broke, requiring open-heart surgery to remove the fragments. The U.S. District Court for the District of Minnesota rejected the manufacturer’s argument in 2008 that Dahl had assumed the risk by signing an informed consent form, noting he was unconscious during the procedure and that acknowledging potential complications does not release a manufacturer from its duties of care.11GovInfo. Dahl v. Atritech, Inc., Civ. No. 07-192
Deadlines and What to Gather
Statutes of limitations for medical device claims typically run two to four years, depending on the state. Many states apply a discovery rule, which starts the clock when the patient discovers, or reasonably should have discovered, that the device caused the injury, not on the date of implantation.7Lawfold. Watchman Device Lawsuit Waiting too long can bar an otherwise strong claim.
Before consulting an attorney who handles medical device cases, gather the operative report from the implantation, post-procedure imaging, discharge records, and any documentation of complications or follow-up care. If a family member died, the death certificate and autopsy report, if one was performed, will matter as well. Those records are what a lawyer needs to tell you whether a manufacturing defect, failure-to-warn, malpractice, or wrongful death theory fits your facts, and whether preemption is likely to be a problem in your case.